ID   UP-019
AC   CVCL_AP57
DR   Wikidata; Q54991547
RX   PubMed=24335698;
RX   PubMed=25550537;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): PubMed=24335698
ST   Amelogenin: X
ST   CSF1PO: 8,11
ST   D13S317: 10,12
ST   D16S539: 11
ST   D21S11: 29
ST   D5S818: 12
ST   D7S820: 9
ST   TH01: 9.3
ST   TPOX: 12
ST   vWA: 17
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 05-10-23; Version: 6
//
RX   PubMed=24335698; DOI=10.1093/neuonc/not202; PMCID=PMC3895385;
RA   An Q., Fillmore H.L., Vouri M., Pilkington G.J.;
RT   "Brain tumor cell line authentication, an efficient alternative to
RT   capillary electrophoresis by using a microfluidics-based system.";
RL   Neuro-oncol. 16:265-273(2014).
//
RX   PubMed=25550537;
RA   Higgins S.C., Fillmore H.L., Ashkan K., Butt A.M., Pilkington G.J.;
RT   "Dual targeting NG2 and GD3A using Mab-Zap immunotoxin results in
RT   reduced glioma cell viability in vitro.";
RL   Anticancer Res. 35:77-84(2015).
//